Compare Strategy Inc. (MSTR) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Novavax Inc — how do they compare? Strategy Inc. trades at $101.97 (market cap $35.47B), while Novavax Inc trades at $8.06 (market cap $1.30B). The key difference: Strategy Inc. is far larger — about 27.3× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| MSTR | NVAX | |
|---|---|---|
Market Cap | $35.47B | $1.30B |
Sector | Technology | Health |
52-Week High | $426.40 | $11.19 |
52-Week Low | $82.31 | $6.22 |
Enterprise Value | $50.50B | $800.50M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
